DDInter1778 DDInter832
A drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders. It is a monoamine depletor and used as symptomatic treatment of chorea associated with Huntington's disease. FDA approved on August 15, 2008.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Tetrabenazine {u} (Compound) resembles {v} (Compound) Donepezil
Tetrabenazine {u} (Compound) binds {v} (Gene) CYP2D6
Tetrabenazine {u} (Compound) upregulates {v} (Gene) WDR61
Tetrabenazine {u} (Compound) is included by {v} (Pharmacologic Class) Vesicular Monoamine Transporter 2 Inhibitors
Tetrabenazine {u} (Compound) downregulates {v} (Gene) GJA1
Tetrabenazine {u} (Compound) causes {v} (Side Effect) Insomnia
Tetrabenazine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Metronidazole
Tetrabenazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Oxaliplatin
Tetrabenazine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Rolapitant
Tetrabenazine {u} may lead to a major life threatening interaction when taken with {v} Osimertinib
Tetrabenazine (Compound) resembles Donepezil (Compound)
Tetrabenazine (Compound) binds CYP2D6 (Gene)
Tetrabenazine (Compound) upregulates WDR61 (Gene)
Tetrabenazine (Compound) is included by Vesicular Monoamine Transporter 2 Inhibitors (Pharmacologic Class)
Tetrabenazine (Compound) downregulates GJA1 (Gene)
Tetrabenazine (Compound) causes Insomnia (Side Effect)
Tetrabenazine may cause a minor interaction that can limit clinical effects when taken with Metronidazole
Tetrabenazine may cause a moderate interaction that could exacerbate diseases when taken with Oxaliplatin
Tetrabenazine may cause a moderate interaction that could exacerbate diseases when taken with Rolapitant
Tetrabenazine may lead to a major life threatening interaction when taken with Osimertinib